Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Thursday, September 30, 2021.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q3 FY2021 (2021-09-30): -336.89%.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
-162.12%
RETURN ON EQUITY (ROE) AVG 3Y
-114.62%
RETURN ON EQUITY (ROE) AVG 5Y
-140.11%
RETURN ON EQUITY (ROE) AVG 10Y
-135.36%
RETURN ON EQUITY (ROE) AVG 15Y
-135.36%
RETURN ON EQUITY (ROE) AVG 20Y
-128.04%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Galectin Therapeutics Inc.
Market Cap
$241.69M
Return on Equity (ROE)
N/A
TTM Avg
-162.12%
3Y Avg
-114.62%
5Y Avg
-140.11%
Market Cap
$242.58M
Return on Equity (ROE)
31.90%
TTM Avg
-385.06%
3Y Avg
-191.20%
5Y Avg
-142.10%
Market Cap
$242.50M
Return on Equity (ROE)
N/A
TTM Avg
-1340.59%
3Y Avg
-55.32%
5Y Avg
-61.68%
Market Cap
$239.25M
Return on Equity (ROE)
-695.56%
TTM Avg
-3698.55%
3Y Avg
-1897.26%
5Y Avg
-1268.80%
Market Cap
$246.48M
Return on Equity (ROE)
-33.97%
TTM Avg
-31.77%
3Y Avg
-42.34%
5Y Avg
-36.86%
Market Cap
$237.83M
Return on Equity (ROE)
N/A
TTM Avg
-125.28%
3Y Avg
-42.20%
5Y Avg
-43.41%
Market Cap
$237.69M
Return on Equity (ROE)
-31.55%
TTM Avg
-30.05%
3Y Avg
-33.97%
5Y Avg
-37.95%
Market Cap
$245.79M
Return on Equity (ROE)
-47.25%
TTM Avg
-42.23%
3Y Avg
-50.43%
5Y Avg
-29.25%
Market Cap
$246.29M
Return on Equity (ROE)
-54.67%
TTM Avg
-46.45%
3Y Avg
-41.29%
5Y Avg
-47.75%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Galectin Therapeutics Inc. (GALT) | $241.69M | N/A | -162.12% | -114.62% | -140.11% |
| Q32 Bio Inc. (QTTB)vs › | $242.58M | 31.90% | -385.06% | -191.20% | -142.10% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $242.50M | N/A | -1340.59% | -55.32% | -61.68% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $239.25M | -695.56% | -3698.55% | -1897.26% | -1268.80% |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $246.48M | -33.97% | -31.77% | -42.34% | -36.86% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $237.83M | N/A | -125.28% | -42.20% | -43.41% |
| High Tide Inc. (HITI)vs › | $237.69M | -31.55% | -30.05% | -33.97% | -37.95% |
| Century Therapeutics, Inc. (IPSC)vs › | $245.79M | -47.25% | -42.23% | -50.43% | -29.25% |
| Quantum-Si incorporated (QSI)vs › | $246.29M | -54.67% | -46.45% | -41.29% | -47.75% |
| Invivyd, Inc. (IVVD)vs › | $236.86M | -59.27% | -136.66% | -113.26% | -53.68% |
ROE
N/A
ROA
-187.8%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2021-09-30 | -336.89% |
| 2021-06-30 | -166.99% |
| 2021-03-31 | -143.95% |
| 2020-12-31 | -96.99% |
| 2020-09-30 | -65.79% |
| 2020-06-30 | -47.53% |
| 2020-03-31 | -33.86% |
| 2019-12-31 | -29.16% |
| 2019-09-30 | -22.65% |
| 2019-06-30 | -21.65% |
| 2019-03-31 | -175.64% |
| 2018-12-31 | -201.51% |
| 2018-09-30 | -147.51% |
| 2018-06-30 | -152.31% |
| 2018-03-31 | -587.46% |
| 2017-09-30 | -690.79% |
| 2017-06-30 | -319.10% |
| 2017-03-31 | -203.14% |
| 2016-12-31 | -178.41% |
| 2016-09-30 | -178.88% |
| 2016-06-30 | -156.57% |
| 2016-03-31 | -112.61% |
| 2015-12-31 | -79.95% |
| 2015-09-30 | -96.47% |
| 2015-06-30 | -67.49% |
| 2015-03-31 | -54.05% |
| 2014-12-31 | -56.44% |
| 2014-09-30 | -49.62% |
| 2014-06-30 | -45.86% |
| 2014-03-31 | -40.03% |
| 2013-12-31 | -146.93% |
| 2013-09-30 | -897.31% |
| 2013-06-30 | -290.10% |
| 2013-03-31 | -190.95% |
| 2012-12-31 | -122.21% |
| 2012-09-30 | -348.94% |
| 2012-06-30 | -203.95% |
| 2012-03-31 | -153.47% |
| 2011-06-30 | -803.93% |
| 2007-06-30 | 698.22% |
| 2007-03-31 | 993.32% |
| 2005-12-31 | -182.64% |
| 2005-09-30 | -130.55% |
| 2005-06-30 | -100.44% |
| 2005-03-31 | -77.47% |
| 2004-12-31 | -71.06% |
| 2004-09-30 | -53.95% |
| 2004-06-30 | -73.34% |
| 2004-03-31 | -98.80% |
| 2003-12-31 | -63.92% |
| 2003-09-30 | -93.07% |
| 2003-06-30 | -206.88% |
